Discovery Life Sciences Announces New CEO | Discovery Life Sciences Announces Major Strategic Expansions: New State-of-the-Art Facilities, Advanced Technologies, and Global Brand Enhancements | Discovery Life Sciences expands high-throughput proteomics services | Discovery Life Sciences Accelerates Clinical Trials with Addition of Full-Spectrum Clinical Flow Cytometry |

How are the cell counts and viabilities of BMMCs determined?

Cell counts and viability are determined using AOPI staining on a Nexcelom Cellometer.